Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah C Gilbert

Showing results (11-20 of 215) with videos related to

Pageof 22
Sort By:
Journal of Virological Methods|April 27, 2010
Rapid generation of markerless recombinant MVA vaccines by en passant recombineering of a self-excising bacterial artificial chromosomeMatthew G Cottingham, Sarah C Gilbert
Immunology Letters|April 27, 2019
Vaccine platforms for the prevention of Lassa feverJyothi Purushotham, Teresa Lambe, Sarah C Gilbert
Vaccine|June 11, 2013
Utilizing poxviral vectored vaccines for antibody induction-progress and prospectsSimon J Draper, Matthew G Cottingham, Sarah C Gilbert
Vaccine|July 10, 2013
Poxvirus vectorsJoost H C M Kreijtz, Sarah C Gilbert, Gerd Sutter
Future Virology|March 13, 2018
Simian adenoviruses as vaccine vectorsSusan J Morris, Sarah Sebastian, Alexandra J Spencer, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 5, 2017
Generation and Production of Modified Vaccinia Virus Ankara (MVA) as a Vaccine VectorVincent Pavot, Sarah Sebastian, Alison V Turner, et al.
The Lancet. Infectious Diseases|January 18, 2015
Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseasesClaire M Tully, Teresa Lambe, Sarah C Gilbert, et al.
Plos One|May 27, 2015
Investigation of IRES Insertion into the Genome of Recombinant MVA as a Translation Enhancer in the Context of Transcript DecappingNaif Khalaf Alharbi, Senthil K Chinnakannan, Sarah C Gilbert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
Novel protein and poxvirus-based vaccine combinations for simultaneous induction of humoral and cell-mediated immunityClaire L Hutchings, Sarah C Gilbert, Adrian V S Hill, et al.
Plos One|May 24, 2011
Dual neonate vaccine platform against HIV-1 and M. tuberculosisRichard Hopkins, Anne Bridgeman, Joan Joseph, et al.
Pageof 22

Showing results (11-20 of 215) with videos related to

Sort By:
Pageof 22
Journal of Virological Methods|April 27, 2010
Rapid generation of markerless recombinant MVA vaccines by en passant recombineering of a self-excising bacterial artificial chromosomeMatthew G Cottingham, Sarah C Gilbert
Immunology Letters|April 27, 2019
Vaccine platforms for the prevention of Lassa feverJyothi Purushotham, Teresa Lambe, Sarah C Gilbert
Vaccine|June 11, 2013
Utilizing poxviral vectored vaccines for antibody induction-progress and prospectsSimon J Draper, Matthew G Cottingham, Sarah C Gilbert
Vaccine|July 10, 2013
Poxvirus vectorsJoost H C M Kreijtz, Sarah C Gilbert, Gerd Sutter
Future Virology|March 13, 2018
Simian adenoviruses as vaccine vectorsSusan J Morris, Sarah Sebastian, Alexandra J Spencer, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 5, 2017
Generation and Production of Modified Vaccinia Virus Ankara (MVA) as a Vaccine VectorVincent Pavot, Sarah Sebastian, Alison V Turner, et al.
The Lancet. Infectious Diseases|January 18, 2015
Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseasesClaire M Tully, Teresa Lambe, Sarah C Gilbert, et al.
Plos One|May 27, 2015
Investigation of IRES Insertion into the Genome of Recombinant MVA as a Translation Enhancer in the Context of Transcript DecappingNaif Khalaf Alharbi, Senthil K Chinnakannan, Sarah C Gilbert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
Novel protein and poxvirus-based vaccine combinations for simultaneous induction of humoral and cell-mediated immunityClaire L Hutchings, Sarah C Gilbert, Adrian V S Hill, et al.
Plos One|May 24, 2011
Dual neonate vaccine platform against HIV-1 and M. tuberculosisRichard Hopkins, Anne Bridgeman, Joan Joseph, et al.
Pageof 22